{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:55:30Z","timestamp":1795089330903,"version":"4.10.2"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40292-022-00506-9","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T04:22:41Z","timestamp":1645330961000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Hypertension and COVID-19: Current Evidence and Perspectives"],"prefix":"10.1007","volume":"29","author":[{"given":"Giovanna","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Calvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-1959","authenticated-orcid":false,"given":"Carmine","family":"Savoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,20]]},"reference":[{"issue":"15","key":"506_CR1","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMsb2021088","volume":"383","author":"D Blumenthal","year":"2020","unstructured":"Blumenthal D, Fowler EJ, Abrams M, Collins SR. Covid-19\u2014implications for the health care system. N Engl J Med. 2020;383(15):1483\u20132148.","journal-title":"N Engl J Med"},{"key":"506_CR2","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) dashboard. https:\/\/covid19.who.int. Accessed 21 Oct 2021."},{"key":"506_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","volume":"76","author":"G Iaccarino","year":"2020","unstructured":"Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M, SARSRAS Investigators. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS Study of the Italian Society of hypertension. Hypertension. 2020;76:366\u201372.","journal-title":"Hypertension"},{"key":"506_CR4","doi-asserted-by":"crossref","unstructured":"Mancusi C, Grassi G, Borghi C, Carugo S, Fallo F, Ferri C, Giannattasio C, Grassi D, Letizia C, Minuz P, et al, SARS-RAS Investigators. Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of hypertension. J Hypertens. 2021;39:376\u201380.","DOI":"10.1097\/HJH.0000000000002666"},{"key":"506_CR5","doi-asserted-by":"crossref","first-page":"100158","DOI":"10.1016\/j.lanepe.2021.100158","volume":"8","author":"L Semenzato","year":"2021","unstructured":"Semenzato L, Botton J, Drouin J, Cuenot F, Dray-Spira R, Weill A, Zureik M. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health Eur. 2021;8:100158.","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"506_CR6","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1038\/s41598-021-88130-w","volume":"11","author":"B Thakur","year":"2021","unstructured":"Thakur B, Dubey P, Benitez J, Torres JP, Reddy S, Shokar N, Aung K, Mukherjee D, Dwivedi AK. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. 2021;11(1):8562.","journal-title":"Sci Rep"},{"key":"506_CR7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S2213-2600(20)30165-X","volume":"8","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Taccone FS. Understanding pathways to death in patients with COVID-19. Lancet Respir Med. 2020;8:430\u20132.","journal-title":"Lancet Respir Med"},{"key":"506_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13054-020-02902-w","volume":"24","author":"G Deng","year":"2020","unstructured":"Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24:179.","journal-title":"Crit Care"},{"key":"506_CR9","doi-asserted-by":"crossref","unstructured":"Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, et al, ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985.","DOI":"10.1136\/bmj.m1985"},{"issue":"33","key":"506_CR10","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"key":"506_CR11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","volume":"38","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38:982\u20131004.","journal-title":"J Hypertens"},{"issue":"19","key":"506_CR12","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127\u2013248.","journal-title":"J Am Coll Cardiol"},{"key":"506_CR13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","volume":"116","author":"R Kreutz","year":"2020","unstructured":"Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, et al. Hypertension, the renin\u2013angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res. 2020;116:1688\u201399.","journal-title":"Cardiovasc Res"},{"key":"506_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.e8.","journal-title":"Cell"},{"key":"506_CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kru\u00c3\u00e0ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.e8.","journal-title":"Cell"},{"issue":"6","key":"506_CR16","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"AHJ Danser","year":"2020","unstructured":"Danser AHJ, Epstein M, Batlle D. Renin\u2013angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin\u2013angiotensin system blockers. Hypertension. 2020;75(6):1382\u20135.","journal-title":"Hypertension"},{"issue":"25","key":"506_CR17","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS. Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382(25):2441\u20138.","journal-title":"N Engl J Med"},{"key":"506_CR18","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380."},{"issue":"3","key":"506_CR19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ajh\/hpaa225","volume":"34","author":"A Caillon","year":"2021","unstructured":"Caillon A, Zhao K, Klein KO, Greenwood C, Lu Z, Paradis P, Schiffrin EL. High systolic blood pressure at hospital admission is an important risk factor in models predicting outcome of COVID-19 patients. Am J Hypertens. 2021;34(3):282\u201390.","journal-title":"Am J Hypertens"},{"issue":"7","key":"506_CR20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCRESAHA.121.318054","volume":"128","author":"C Savoia","year":"2021","unstructured":"Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19: current views and perspectives. Circ Res. 2021;128(7):1062\u201379.","journal-title":"Circ Res"},{"issue":"3","key":"506_CR21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/HYPERTENSIONAHA.120.16563","volume":"77","author":"E Rodilla","year":"2021","unstructured":"Rodilla E, L\u00f3pez-Carmona MD, Cortes X, Cobos-Palacios L, Canales S, S\u00e1ez MC, Campos Escudero S, Rubio-Rivas M, D\u00edez Manglano J, Freire Castro SJ, V\u00e1zquez Piqueras N, Mateo Sanchis E, Pesqueira Fontan PM, Magallanes Gamboa JO, Gonz\u00e1lez Garc\u00eda A, Madrid Romero V, Tamargo Chamorro L, Gonz\u00e1lez Moraleja J, Villanueva Mart\u00ednez J, Gonz\u00e1lez Noya A, Su\u00e1rez-Lombra\u00f1a A, Gracia Guti\u00e9rrez A, L\u00f3pez Reboiro ML, Ramos Rinc\u00f3n JM, G\u00f3mez Huelgas R, SEMI-COVID-19 Network. Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain. Hypertension. 2021;77(3):856\u201367.","journal-title":"Hypertension"},{"issue":"6","key":"506_CR22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/HJH.0000000000002770","volume":"39","author":"R Kreutz","year":"2021","unstructured":"Kreutz R, Dobrowolski P, Prejbisz A, Algharably EAE, Bilo G, Creutzig F, Grassi G, Kotsis V, Lovic D, Lurbe E, Modesti PA, Pappaccogli M, Parati G, Persu A, Polonia J, Rajzer M, de Timary P, Weber T, Weisser B, Tsioufis K, Mancia G, Januszewicz A, European Society of Hypertension COVID-19 Task Force Review. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021;39(6):1077\u201389.","journal-title":"J Hypertens"},{"issue":"5","key":"506_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40292-020-00407-9","volume":"27","author":"M Volpe","year":"2020","unstructured":"Volpe M, Gallo G. COVID-19 and the forgotten majority. High Blood Press Cardiovasc Prev. 2020;27(5):339.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"506_CR24","doi-asserted-by":"crossref","unstructured":"Safar ME, Asmar R, Benetos A, Blacher J, Boutouyrie P, Lacolley P, Laurent S, London G, Pannier B, Protogerou A, et al, French Study Group on Arterial Stiffness. Interaction between hypertension and arterial stiffness. Hypertension. 2018;72:796\u2013805.","DOI":"10.1161\/HYPERTENSIONAHA.118.11212"},{"key":"506_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40292-020-00395-w","volume":"27","author":"A Battistoni","year":"2020","unstructured":"Battistoni A, Michielon A, Marino G, Savoia C. Vascular aging and central aortic blood pressure: from pathophysiology to treatment. High Blood Press Cardiovasc Prev. 2020;27:299\u2013308.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"506_CR26","doi-asserted-by":"crossref","unstructured":"Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, et al, Mount Sinai COVID Informatics Center. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76:533\u201346.","DOI":"10.1101\/2020.04.20.20072702"},{"issue":"10251","key":"506_CR27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(20)31759-1","volume":"396","author":"F Braun","year":"2020","unstructured":"Braun F, L\u00fctgehetmann M, Pfefferle S, Wong MN, Carsten A, Lindenmeyer MT, N\u00f6rz D, Heinrich F, Mei\u00dfner K, Wichmann D, Kluge S, Gross O, Pueschel K, Schr\u00f6der AS, Edler C, Aepfelbacher M, Puelles VG, Huber TB. SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet. 2020;396(10251):597\u20138.","journal-title":"Lancet"},{"key":"506_CR28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cophys.2020.09.016","volume":"19","author":"DM Patrick","year":"2021","unstructured":"Patrick DM, Van Beusecum JP, Kirabo A. The role of inflammation in hypertension: novel concepts. Curr Opin Physiol. 2021;19:92\u20138.","journal-title":"Curr Opin Physiol"},{"key":"506_CR29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/cvr\/cvy252","volume":"115","author":"SM Krishnan","year":"2019","unstructured":"Krishnan SM, Ling YH, Huuskes BM, Ferens DM, Saini N, Chan CT, Diep H, Kett MM, Samuel CS, Kemp-Harper BK, et al. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res. 2019;115:776\u201387.","journal-title":"Cardiovasc Res"},{"key":"506_CR30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/CIRCULATIONAHA.119.045102","volume":"141","author":"M Siedlinski","year":"2020","unstructured":"Siedlinski M, Jozefczuk E, Xu X, Teumer A, Evangelou E, Schnabel RB, Welsh P, Maffia P, Erdmann J, Tomaszewski M, et al. White blood cells and blood pressure: a Mendelian Randomization Study. Circulation. 2020;141:1307\u201317.","journal-title":"Circulation"},{"key":"506_CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","volume":"68","author":"HA Itani","year":"2016","unstructured":"Itani HA, McMaster WG Jr, Saleh MA, Nazarewicz RR, Mikolajczyk TP, Kaszuba AM, Konior A, Prejbisz A, Januszewicz A, Norlander AE, et al. Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans. Hypertension. 2016;68:123\u201332.","journal-title":"Hypertension"},{"key":"506_CR32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.113.00689","volume":"62","author":"JC Youn","year":"2013","unstructured":"Youn JC, Yu HT, Lim BJ, Koh MJ, Lee J, Chang DY, Choi YS, Lee SH, Kang SM, Jang Y, et al. Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension. 2013;62:126\u201333.","journal-title":"Hypertension"},{"key":"506_CR33","doi-asserted-by":"crossref","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20131034.","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"506_CR34","doi-asserted-by":"crossref","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al, Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950\u201373.","DOI":"10.1016\/j.jacc.2020.04.031"},{"issue":"11","key":"506_CR35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","volume":"5","author":"D Lindner","year":"2020","unstructured":"Lindner D, Fitzek A, Br\u00e4uninger H, Aleshcheva G, Edler C, Meissner K, Scherschel K, Kirchhof P, Escher F, Schultheiss HP, Blankenberg S, P\u00fcschel K, Westermann D. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281\u20135.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"506_CR36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","volume":"201","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299\u2013300.","journal-title":"Am J Respir Crit Care Med"},{"key":"506_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2015432.","journal-title":"N Engl J Med"},{"key":"506_CR38","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","volume":"116","author":"PC Evans","year":"2020","unstructured":"Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science. Cardiovasc Res. 2020;116:2177\u201384.","journal-title":"Cardiovasc Res"},{"key":"506_CR39","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417\u20138.","journal-title":"Lancet"},{"key":"506_CR40","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.7326\/L20-0882","volume":"173","author":"SE Fox","year":"2020","unstructured":"Fox SE, Lameira FS, Rinker EB, Vander Heide RS. Cardiac endotheliitis and multisystem inflammatory syndrome after covid-19. Ann Intern Med. 2020;173:1025\u20137.","journal-title":"Ann Intern Med"},{"key":"506_CR41","first-page":"152","volume":"15","author":"C Savoia","year":"2006","unstructured":"Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006;15:152\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"506_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20060247","volume":"112","author":"C Savoia","year":"2007","unstructured":"Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond). 2007;112(7):375\u201384.","journal-title":"Clin Sci (Lond)"},{"key":"506_CR43","doi-asserted-by":"crossref","first-page":"281240","DOI":"10.4061\/2011\/281240","volume":"2011","author":"C Savoia","year":"2011","unstructured":"Savoia C, Sada L, Zezza L, Pucci L, Lauri FM, Befani A, Alonzo A, Volpe M. Vascular inflammation and endothelial dysfunction in experimental hypertension. Int J Hypertens. 2011;2011:281240.","journal-title":"Int J Hypertens"},{"issue":"12","key":"506_CR44","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/bph.14427","volume":"176","author":"A Caillon","year":"2019","unstructured":"Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension. Br J Pharmacol. 2019;176(12):1818\u201328.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"506_CR45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","volume":"5","author":"Y Jin","year":"2020","unstructured":"Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;5(1):293.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"506_CR46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cjca.2020.02.081","volume":"36","author":"RM Touyz","year":"2020","unstructured":"Touyz RM, Rios FJ, Alves-Lopes R, Neves KB, Camargo LL, Montezano AC. Oxidative stress: a unifying paradigm in hypertension. Can J Cardiol. 2020;36(5):659\u201370.","journal-title":"Can J Cardiol"},{"issue":"12","key":"506_CR47","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1161\/ATVBAHA.116.308339","volume":"36","author":"JD La Favor","year":"2016","unstructured":"La Favor JD, Dubis GS, Yan H, White JD, Nelson MA, Anderson EJ, Hickner RC. Microvascular endothelial dysfunction in sedentary, obese humans is mediated by NADPH oxidase: influence of exercise training. Arterioscler Thromb Vasc Biol. 2016;36(12):2412\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"506_CR48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2016.12.019","volume":"109","author":"S Godo","year":"2017","unstructured":"Godo S, Shimokawa H. Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis. Free Radic Biol Med. 2017;109:4\u201310.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"506_CR49","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1440-1681.2003.03930.x","volume":"30","author":"RM Touyz","year":"2003","unstructured":"Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol. 2003;30(11):860\u20136.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"506_CR50","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/HYPERTENSIONAHA.120.15527","volume":"76","author":"C Savoia","year":"2020","unstructured":"Savoia C, Arrabito E, Parente R, Nicoletti C, Madaro L, Battistoni A, Filippini A, Steckelings UM, Touyz RM, Volpe M. Mas receptor activation contributes to the improvement of nitric oxide bioavailability and vascular remodeling during chronic AT1R (Angiotensin Type-1 Receptor) blockade in experimental hypertension. Hypertension. 2020;76:1753\u201361.","journal-title":"Hypertension"},{"key":"506_CR51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","volume":"17","author":"S Lavandero","year":"2020","unstructured":"Lavandero S. Counter-regulatory renin\u2013angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17:116\u201329.","journal-title":"Nat Rev Cardiol"},{"key":"506_CR52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","volume":"98","author":"RAS Santos","year":"2018","unstructured":"Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ. The ACE2\/Angiotensin-(1\u20137)\/MAS axis of the renin\u2013angiotensin system: focus on angiotensin-(1\u20137). Physiol Rev. 2018;98:505\u201353.","journal-title":"Physiol Rev"},{"key":"506_CR53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MNH.0b013e3283437fcd","volume":"20","author":"C Savoia","year":"2011","unstructured":"Savoia C, D\u2019Agostino M, Lauri F, Volpe M. Angiotensin type 2 receptor in hypertensive cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20:125\u201332.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"506_CR54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20200480","volume":"135","author":"J Kuriakose","year":"2021","unstructured":"Kuriakose J, Montezano AC, Touyz RM. ACE2\/Ang-(1\u20137)\/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci (Lond). 2021;135:387\u2013407.","journal-title":"Clin Sci (Lond)"},{"key":"506_CR55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/hr.2009.191","volume":"33","author":"J Kamilic","year":"2010","unstructured":"Kamilic J, Hamming I, Kreutz R, Bolbrinker J, Siems WE, Nassar I, Sluimer JC, Walther T, Navis GJ, van Goor H. Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27. Hypertens Res. 2010;33:123\u20138.","journal-title":"Hypertens Res"},{"key":"506_CR56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fphys.2014.00227","volume":"5","author":"SK Patel","year":"2014","unstructured":"Patel SK, Velkoska E, Freeman M, Wai B, Lancefield TF, Burrell LM. From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. Front Physiol. 2014;5:227.","journal-title":"Front Physiol"},{"key":"506_CR57","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/HYPERTENSIONAHA.108.114322","volume":"52","author":"B Rentzsch","year":"2008","unstructured":"Rentzsch B, Todiras M, Iliescu R, Popova E, Campos LA, Oliveira ML, Baltatu OC, Santos RA, Bader M. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension. 2008;52:967\u201373.","journal-title":"Hypertension"},{"key":"506_CR58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1152\/physiolgenomics.00312.2005","volume":"27","author":"C D\u00edez-Freire","year":"2006","unstructured":"D\u00edez-Freire C, V\u00e1zquez J, Correa de Adjounian MF, Ferrari MF, Yuan L, Silver X, Torres R, Raizada MK. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genom. 2006;27:12\u20139.","journal-title":"Physiol Genom"},{"key":"506_CR59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1113\/expphysiol.2012.067165","volume":"98","author":"J Lo","year":"2013","unstructured":"Lo J, Patel VB, Wang Z, Levasseur J, Kaufman S, Penninger JM, Oudit GY. Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar\u2013Kyoto rats and spontaneously hypertensive rats. Exp Physiol. 2013;98:109\u201322.","journal-title":"Exp Physiol"},{"key":"506_CR60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215\u201320.","journal-title":"Nature"},{"key":"506_CR61","doi-asserted-by":"crossref","first-page":"e9610","DOI":"10.15252\/msb.20209610","volume":"16","author":"F Hikmet","year":"2020","unstructured":"Hikmet F, M\u00e9ar L, Edvinsson \u00c5, Micke P, Uhl\u00e9n M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020;16:e9610.","journal-title":"Mol Syst Biol"},{"key":"506_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08037051.2021.1862483","volume":"30","author":"SE Kjeldsen","year":"2021","unstructured":"Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S. Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin\u2013angiotensin system to beta-adrenergic receptor blockers. Blood Press. 2021;30:1\u20133.","journal-title":"Blood Press"},{"issue":"1","key":"506_CR63","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1038\/s41467-020-18880-0","volume":"11","author":"H Jia","year":"2020","unstructured":"Jia H, Yue X, Lazartigues E. ACE2 mouse models: a toolbox for cardiovascular and pulmonary research. Nat Commun. 2020;11(1):5165.","journal-title":"Nat Commun"},{"key":"506_CR64","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1038\/s41467-020-19145-6","volume":"11","author":"IT Lee","year":"2020","unstructured":"Lee IT, Nakayama T, Wu CT, Goltsev Y, Jiang S, Gall PA, Liao CK, Shih LC, Sch\u00fcrch CM, McIlwain DR, et al. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs. Nat Commun. 2020;11:5453.","journal-title":"Nat Commun"},{"issue":"6","key":"506_CR65","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","volume":"39","author":"S Trump","year":"2021","unstructured":"Trump S, Lukassen S, Anker MS, Chua RL, Liebig J, Th\u00fcrmann L, Corman VM, Binder M, Loske J, Klasa C, Krieger T, Hennig BP, Messingschlager M, Pott F, Kazmierski J, Twardziok S, Albrecht JP, Eils J, Hadzibegovic S, Lena A, Heidecker B, B\u00fcrgel T, Steinfeldt J, Goffinet C, Kurth F, Witzenrath M, V\u00f6lker MT, M\u00fcller SD, Liebert UG, Ishaque N, Kaderali L, Sander LE, Drosten C, Laudi S, Eils R, Conrad C, Landmesser U, Lehmann I. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol. 2021;39(6):705\u201316.","journal-title":"Nat Biotechnol"},{"key":"506_CR66","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1093\/eurheartj\/ehaa794","volume":"41","author":"X Jiang","year":"2020","unstructured":"Jiang X, Eales JM, Scannali D, Nazgiewicz A, Prestes P, Maier M, Denniff M, Xu X, Saluja S, Cano-Gamez E, et al. Hypertension and renin\u2013angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney. Eur Heart J. 2020;41:4580\u20138.","journal-title":"Eur Heart J"},{"issue":"25","key":"506_CR67","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382(25):2431\u201340.","journal-title":"N Engl J Med"},{"key":"506_CR68","doi-asserted-by":"crossref","unstructured":"de Abajo FJ, Rodr\u00edguez-Mart\u00edn S, Lerma V, Mej\u00eda-Abril G, Aguilar M, Garc\u00eda-Luque A, Laredo L, Laosa O, Centeno-Soto GA, \u00c1ngeles G\u00e1lvez M, et al, MED-ACE2-COVID19 study group. Use of renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395:1705\u201314.","DOI":"10.1016\/S0140-6736(20)31030-8"},{"key":"506_CR69","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.120.15464","volume":"76","author":"M Son","year":"2020","unstructured":"Son M, Seo J, Yang S. Association between renin\u2013angiotensin\u2013aldosterone system inhibitors and COVID-19 infection in South Korea. Hypertension. 2020;76:742\u20139.","journal-title":"Hypertension"},{"issue":"4","key":"506_CR70","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/HJH.0000000000002784","volume":"39","author":"C Bavishi","year":"2021","unstructured":"Bavishi C, Whelton PK, Mancia G, Corrao G, Messerli FH. Renin\u2013angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies. J Hypertens. 2021;39(4):784\u201394.","journal-title":"J Hypertens"},{"key":"506_CR71","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","volume":"5","author":"N Mehta","year":"2020","unstructured":"Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1020\u20136.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"506_CR72","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2589-7500(20)30289-2","volume":"3","author":"DR Morales","year":"2021","unstructured":"Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte-Salles T, Fern\u00e1ndez-Bertol\u00edn S, Arag\u00f3n M, DuVall SL, Lynch K, Falconer T, van Bochove K, Sung C, Matheny ME, Lambert CG, Nyberg F, Alshammari TM, Williams AE, Park RW, Weaver J, Sena AG, Schuemie MJ, Rijnbeek PR, Williams RD, Lane JCE, Prats-Uribe A, Zhang L, Areia C, Krumholz HM, Prieto-Alhambra D, Ryan PB, Hripcsak G, Suchard MA. Renin\u2013angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health. 2021;3(2):e98\u2013114.","journal-title":"Lancet Digit Health"},{"issue":"3","key":"506_CR73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","volume":"325","author":"RD Lopes","year":"2021","unstructured":"Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L, Feldman A, D\u2019Andr\u00e9a Saba Arruda G, de Albuquerque DC, Camiletti AS, de Sousa AS, de Paula TC, Giusti KGD, Domiciano RAM, Noya-Rabelo MM, Hamilton AM, Loures VA, Dion\u00edsio RM, Furquim TAB, De Luca FA, Dos Santos Sousa \u00cdB, Bandeira BS, Zukowski CN, de Oliveira RGG, Ribeiro NB, de Moraes JL, Petriz JLF, Pimentel AM, Miranda JS, de Jesus Abufaiad BE, Gibson CM, Granger CB, Alexander JH, de Souza OF, BRACE CORONA Investigators. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021;325(3):254\u201364.","journal-title":"JAMA"},{"issue":"3","key":"506_CR74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","volume":"9","author":"JB Cohen","year":"2021","unstructured":"Cohen JB, Hanff TC, William P, Sweitzer N, Rosado-Santander NR, Medina C, Rodriguez-Mori JE, Renna N, Chang TI, Corrales-Medina V, Andrade-Villanueva JF, Barbagelata A, Cristodulo-Cortez R, D\u00edaz-Cucho OA, Spaak J, Alfonso CE, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-Garc\u00eda RJ, Castro-Callirgos CA, Gonz\u00e1lez-Hern\u00e1ndez LA, Bernales-Salas EF, Coacalla-Guerra JC, Salinas-Herrera CD, Nicolosi L, Basconcel M, Byrd JB, Sharkoski T, Bendez\u00fa-Huasasquiche LE, Chittams J, Edmonston DL, Vasquez CR, Chirinos JA. Continuation versus discontinuation of renin\u2013angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021;9(3):275\u201384.","journal-title":"Lancet Respir Med"},{"key":"506_CR75","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.eclinm.2021.100962","volume":"37","author":"M Duarte","year":"2021","unstructured":"Duarte M, Pelorosso F, Nicolosi LN, Salgado MV, Vetulli H, Aquieri A, Azzato F, Castro M, Coyle J, Davolos I, Criado IF, Gregori R, Mastrodonato P, Rubio MC, Sarquis S, Wahlmann F, Rothlin RP. Telmisartan for treatment of Covid-19 patients: an open multicenter randomized clinical trial. EClinicalMedicine. 2021;37:100962.","journal-title":"EClinicalMedicine"},{"issue":"8","key":"506_CR76","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(21)00214-9","volume":"9","author":"A Bauer","year":"2021","unstructured":"Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, G\u00e4nzer H, von Bary C, May AE, W\u00f6ll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, K\u00e4\u00e4b S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von St\u00fclpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S, ACEI-COVID Investigators. Discontinuation versus continuation of renin\u2013angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med. 2021;9(8):863\u201372.","journal-title":"Lancet Respir Med"},{"key":"506_CR77","doi-asserted-by":"crossref","first-page":"106330","DOI":"10.1016\/j.cct.2021.106330","volume":"103","author":"V Ajmera","year":"2021","unstructured":"Ajmera V, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Sriram K, Insel PA, Collier S, Richards L, Loomba R. RAMIC: design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp Clin Trials. 2021;103:106330.","journal-title":"Contemp Clin Trials"},{"key":"506_CR78","doi-asserted-by":"crossref","first-page":"643721","DOI":"10.3389\/fphys.2021.643721","volume":"12","author":"S Rubattu","year":"2021","unstructured":"Rubattu S, Gallo G, Volpe M. A contemporary view of natriuretic peptides in the SARS-CoV-2 era. Front Physiol. 2021;12:643721.","journal-title":"Front Physiol"},{"key":"506_CR79","unstructured":"The European Society for Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance. Accessed 21 Apr 2020."},{"key":"506_CR80","doi-asserted-by":"crossref","unstructured":"Volpe M, Battistoni A, Bellotti P, Bellone S, Bertolotti M, Biffi A, Consoli A, Corsini A, Desideri G, Ferri C, et al, Board of the Italian Society of Cardiovascular Prevention. Recommendations for cardiovascular prevention during the Sars-Cov-2 pandemic: an executive document by the board of the Italian Society of cardiovascular prevention. High Blood Press Cardiovasc Prev. 2020;27:373\u20137.","DOI":"10.1007\/s40292-020-00401-1"}],"container-title":["High Blood Pressure &amp; Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-022-00506-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-022-00506-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-022-00506-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:48:32Z","timestamp":1648039712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-022-00506-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,20]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1007\/s40292-022-00506-9","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,20]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}